Osteoporosis: how long should we treat? [electronic resource]
Producer: 20081218Description: 502-7 p. digitalISSN:- 1752-2978
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Clinical Protocols -- standards
- Denosumab
- Diphosphonates -- administration & dosage
- Hip Fractures -- prevention & control
- Humans
- Osteoporosis -- drug therapy
- RANK Ligand -- administration & dosage
- Spinal Fractures -- prevention & control
- Withholding Treatment -- standards
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.